Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 22188159)

1.

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?

Tomljenovic L, Shaw CA.

Ann Med. 2013 Mar;45(2):182-93. doi: 10.3109/07853890.2011.645353. Epub 2011 Dec 22. Review.

PMID:
22188159
2.

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?

Fastrez M, Naik HN, Corfers A, Rozenberg S.

Ann Med. 2012 Jun;44(4):404. doi: 10.3109/07853890.2012.671539. Epub 2012 Apr 2. No abstract available.

PMID:
22462602
3.

Efficacy and other milestones for human papillomavirus vaccine introduction.

Pagliusi SR, Teresa Aguado M.

Vaccine. 2004 Dec 16;23(5):569-78. Review.

PMID:
15630792
4.

The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.

Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM.

Eur J Gynaecol Oncol. 2005;26(2):129-42. Review.

PMID:
15857016
5.

Human Pappilomavirus (HPV) induced cancers and prevention by immunization.

Khaliq SA, Shyum Naqvi SB, Fatima A.

Pak J Pharm Sci. 2012 Oct;25(4):763-72.

PMID:
23009992
6.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

7.

Vaccines against human papillomavirus and cervical cancer: promises and challenges.

Mahdavi A, Monk BJ.

Oncologist. 2005 Aug;10(7):528-38. Review.

8.
9.
10.

[Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].

Monsonego J.

Presse Med. 2007 Apr;36(4 Pt 2):640-66. Epub 2007 Mar 12. Review. French. Erratum in: Presse Med. 2007 Jul-Aug;36(7-8):1150-1.

PMID:
17350792
11.

[Human papillomavirus prophylactic vaccines: stakes and perspectives].

Hantz S, Alain S, Denis F.

Gynecol Obstet Fertil. 2006 Jul-Aug;34(7-8):647-55. Epub 2006 Jun 27. Review. French.

PMID:
16807045
12.

[Cervical cancer prevention: the impact of HPV vaccination].

Monsonégo J.

Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. Epub 2006 Mar 10. Review. French.

PMID:
16529969
14.

Implementation of human papillomavirus immunization in the developing world.

Kane MA, Serrano B, de Sanjosé S, Wittet S.

Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Review.

PMID:
23199963
15.

Preventive and therapeutic HPV vaccines.

Monie A, Hung CF, Wu TC.

Curr Opin Investig Drugs. 2007 Dec;8(12):1038-50. Review.

PMID:
18058574
16.

Human papillomavirus vaccines: current status and future prospects.

Garland SM, Smith JS.

Drugs. 2010 Jun 18;70(9):1079-98. doi: 10.2165/10898580-000000000-00000. Review.

PMID:
20518577
17.

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

Kaufmann AM, Stern PL, Rankin EM, Sommer H, Nuessler V, Schneider A, Adams M, Onon TS, Bauknecht T, Wagner U, Kroon K, Hickling J, Boswell CM, Stacey SN, Kitchener HC, Gillard J, Wanders J, Roberts JS, Zwierzina H.

Clin Cancer Res. 2002 Dec;8(12):3676-85.

18.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
19.

Education about human papillomavirus and human papillomavirus vaccines in adolescents.

Kollar LM, Kahn JA.

Curr Opin Obstet Gynecol. 2008 Oct;20(5):479-83. doi: 10.1097/GCO.0b013e32830d0cf6. Review.

PMID:
18797272
20.

Planning for the HPV vaccine and its impact on cervical cancer prevention.

Bailey J, Cymet TC.

Compr Ther. 2006 Summer;32(2):102-5.

PMID:
16845153
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk